CODX Non Current Assets Total from 2010 to 2025

CODX Stock  USD 0.78  0.06  8.33%   
Co Diagnostics Non Current Assets Total yearly trend continues to be fairly stable with very little volatility. Non Current Assets Total are likely to outpace its year average in 2025. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2016-12-31
Previous Quarter
32.5 M
Current Value
32.3 M
Quarterly Volatility
18.6 M
 
Covid
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 17.2 M or Total Revenue of 7.4 M, as well as many indicators such as Price To Sales Ratio of 6.26, Dividend Yield of 0.0 or PTB Ratio of 0.5. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Co Diagnostics over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Co Diagnostics' Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
631.2.9M44.930.433.238.240.1356%1461%-32%9%15%5%100%
       Timeline  

CODX Non Current Assets Total Regression Statistics

Arithmetic Mean12,018,059
Geometric Mean1,354,090
Coefficient Of Variation148.83
Mean Deviation15,822,206
Median501,259
Standard Deviation17,886,514
Sample Variance319.9T
Range44.8M
R-Value0.80
Mean Square Error121.5T
R-Squared0.65
Significance0.0002
Slope3,018,702
Total Sum of Squares4798.9T

CODX Non Current Assets Total History

202540.1 M
202438.2 M
202333.2 M
202230.4 M
202144.9 M
20202.9 M
2019631.1 K

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Non Current Assets Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Assets Total38.2 M40.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…